TELEFLEX INCTFX

TELEFLEX INC Revenue Disclosure

10-KFiled Feb 27, 20261 min read
Net Revenues
The following table disaggregates revenue by global product category for the years ended December 31, 2025, 2024 and 2023.
Year Ended December 31,
202520242023
Vascular (1)
$917,731 $903,512 $841,114 
Interventional (1)
647,792 397,340 407,251 
Surgical418,155 404,869 388,325 
Other (2)
9,035 (6,175)75,751 
Net revenues (3)
$1,992,713 $1,699,546 $1,712,441 
(1) During the fourth quarter of 2025, and in conjunction with the Strategic Divestitures classified as discontinued operations, we are combining the portion of our historically presented Anesthesia product category that is not part of the disposal group with our Vascular product category. In addition, we made certain immaterial reclassifications between our Interventional and Vascular product categories. Prior period net revenues have been recast to conform to the new presentation.
(2) Includes adjustments in our reserves related to the Italian payback measure pertaining to prior years (see Note 17 for additional information) and revenues generated under the manufacturing and supply transition agreement related to our Respiratory business divestiture that ended in 2023.
(3) The product categories listed above are presented on a global basis, as each of our reportable segments is defined based on the geographic location of its operations.

Historical Timeline

Fiscal YearFiled
2025Feb 27, 2026Showing above
2024Feb 28, 2025
2023Feb 23, 2024
2022Feb 23, 2023
2021Mar 1, 2022
2020Feb 25, 2021
2019Feb 21, 2020
2018Feb 21, 2019

About Revenue Disclosures

Revenue disclosures under ASC 606 explain how a company identifies performance obligations, allocates transaction prices, and determines when revenue is recognized. This section is essential for understanding whether reported revenue reflects genuine economic activity or aggressive accounting choices. Analysts examine the mix of point-in-time versus over-time recognition, which directly affects revenue timing and comparability.

Key signals: rising contract liabilities (deferred revenue) suggest strong future revenue visibility, while declining contract assets may indicate slowing project milestones. Watch for variable consideration estimates — rebates, returns, and performance bonuses that require management judgment. Significant changes in disaggregated revenue by geography or product line can reveal shifting business mix before it appears in headline numbers. Compare revenue growth against contract liability growth to assess sustainability, and scrutinize any changes in the timing of recognition that coincide with earnings pressure.

Other Available Disclosures

Income TaxesFair ValuePP&EGoodwill & IntangiblesLeasesSegmentsDebtCommitmentsStock CompensationNew StandardsPay vs Performance